Armenia Medical Device Authorities 2026: Ministry of Health and SCDMTE Competence Split

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

For medical devices in Armenia, decision-making power sits with the Ministry of Health (MoH), while technical judgment sits with the Scientific Centre of Drug and Medical Technology Expertise (SCDMTE). The GRZAN practical conclusion: the counterpart for submitting technical documentation is SCDMTE, but the six categories of administrative decisions — registration, refusal of registration, suspension, revocation, reissue and amendment — can only be made by the Ministry of Health, and only on the basis of the expert opinion issued by SCDMTE. Treating the two bodies as interchangeable most commonly results in a technical deficiency letter being handled as an administrative rejection, which needlessly forfeits a deficiency-remedy window worth 30 to 60 working days. Understanding the split of competence between the two institutions is therefore the first thing a manufacturer should map before any submission.

2. Legal basis

Legal instrumentReference / numberPublication (entry into force)Provisions
Decision on the Bodies Implementing Expert Assessments and Professional Inspections in the Field of State Regulation of Medical Device CirculationGovernment of the Republic of Armenia Decision No. 1795-Ն of 2022-11-242022-11-24Entire text
Law of the Republic of Armenia On Medical Assistance and Services to the PopulationNo. ЗР-42 of 1996-03-04; Chapter 10 in the new wording of 2022-07-06Amended by Law No. ЗР-504 of 2024-12-17Article 45
Rules for the Registration and Expert Assessment of Medical Devices for Safety, Quality and EfficacyEEC Council Decision No. 46 of 2016-02-12Amended by Council Decision No. 144 of 2021-12-24Article 16
Ministry of Health regulatory portal of Armenia (State Registration of Medical Devices)—CurrentDescription of competent authorities and procedures

3. Expert insights

Insight 1: Decision No. 1795-Ն vests both expert assessments and professional inspections in a single body. The decision provides that expert evaluations and professional inspections in the field of state regulation of medical device circulation are carried out by the State Non-Commercial Organization Scientific Centre of Drug and Medical Technology Expertise under the Ministry of Health of the Republic of Armenia. GRZAN notes that internationally the centre usually appears under the name SCDMTE (Scientific Centre of Drug and Medical Technology Expertise); its full official name in Armenian and Russian follows the publication of the Ministry of Health, and this guide uniformly uses the designation Scientific Centre of Drug and Medical Technology Expertise (SCDMTE). Companies should always address deficiency responses and technical queries to this centre rather than to the ministry itself.

Insight 2: the functions listed in Article 45 form the mandate of the authorized body. The article provides that the powers of the competent authority in the field of medical device circulation include regulation of circulation, licensing of the statutory types of business activity, state registration, conformity assessment of imported medical devices, organization of expert assessments and professional inspections, and collection and analysis of adverse event (incident) information with the adoption of corresponding decisions. Note that conformity assessment of imported medical devices and state registration are listed as two parallel functions; this is precisely the institutional legal basis for the dual-track arrangement during the transition period.

Insight 3: the roles switch depending on whether Armenia acts as the reference country. Under Article 16 of Decision No. 46, registration is carried out by the reference country on the basis of the expert assessment results and of the harmonization of expert opinions among the recognizing countries. When Armenia acts as the reference country, SCDMTE performs the assessment and issues the expert opinion, and the Ministry of Health issues the certificate. When Armenia acts as a recognizing country, SCDMTE performs the harmonization of the expert opinion of the reference country, and the Ministry of Health decides on recognition on that basis. The same pair of institutions thus operates two entirely different procedural roles, and the authorized representative scope differs accordingly.

Insight 4: the officially published time limits divide the work. The figures published on the official page of the Armenian Ministry of Health are as follows: expert assessment by the reference member state takes up to 60 working days from acceptance of the application; harmonization of the expert opinion by a recognizing member state takes up to 30 working days; the registration decision is made within 10 working days after completion of harmonization; and preparation and issuance of the registration certificate take up to 10 working days. These four figures are the yardstick for diagnosing which institution is holding up a dossier.

4. Practical recommendations

  1. Address the right body for each stage: direct deficiency responses, technical clarifications and test protocol confirmations to SCDMTE; address registration decisions, certificate issuance, and suspension or revocation matters to the Ministry of Health.
  2. Treat deficiency letters as technical procedure: when a deficiency notice arrives, respond point by point according to the technical expectations of SCDMTE, and never process it as an administrative appeal.
  3. Distinguish the two roles: before signing any service agreement, confirm whether Armenia acts as the reference country or the recognizing country in the project, because the required scope of the authorized representative differs (in the recognizing role, the local representative mainly performs harmonization support and submission).
  4. Maintain a dual-channel communication record: keep separate files for correspondence with SCDMTE and with the Ministry of Health, so that applicant response periods can later be evidenced under the time-limit deduction clauses of Decision No. 46.

5. Verification checklist

  1. □ It has been confirmed that the competent authority for this project in Armenia is the Ministry of Health and that the technical body is the Scientific Centre of Drug and Medical Technology Expertise (SCDMTE).
  2. □ Government Decision No. 1795-Ն has been retrieved and the body implementing expert assessments and professional inspections has been confirmed.
  3. □ The six functions listed in Article 45 of the Law On Medical Assistance and Services to the Population have been checked.
  4. □ It has been confirmed whether Armenia acts as the reference country or the recognizing country in this project.
  5. □ The official time limits of 60 / 30 / 10 / 10 working days have been recorded in writing.
  6. □ A dual-channel correspondence ledger for SCDMTE and the Ministry of Health has been established.
  7. □ The scope of authorization of the authorized representative has been confirmed to match its procedural role.

Regulatory information verified as of October 30, 2026.

GRZAN services. GRZAN International supports manufacturers with institution mapping, dossier submission and deficiency management before the Ministry of Health of Armenia and SCDMTE. For inquiries, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail